Autism

Neurologic Clinics

Volumn 21, Issue 4, 2003, Pages 915-932

  Tuchman, Roberto ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ANTICONVULSANT THERAPY; AUTISM; BEHAVIOR THERAPY; CHILD BEHAVIOR; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMMUNICATION DISORDER; EDUCATION PROGRAM; EPILEPTIC DISCHARGE; EVOKED BRAIN STEM RESPONSE; GENETIC RISK; HIPPOCAMPUS; HUMAN; INTERPERSONAL COMMUNICATION; LABORATORY DIAGNOSIS; LANGUAGE DISABILITY; LIMBIC CORTEX; MORPHOMETRICS; NEUROANATOMY; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NORADRENALIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SEIZURE; SOCIAL DISABILITY;

EID: 0142043289     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(03)00011-2     Document Type: Review

References (140)

1. Pervasive developmental disorders. In: American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994. p. 65.
2. Szatmari P. The validity of autistic spectrum disorders: a literature review. J Autism Dev Disord 1992;22:583.
3. Rapin I. The autistic-spectrum disorders. N Engl J Med 2002;347:302.
4. Fombonne E. Epidemiological trends in rates of autism. Mol Psychiatry 2002;7(Suppl 2):S4.
5. Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev 2002;8:151.
6. Tanguay P. Infantile autism and social communication spectrum disorder. J Am Acad Child Adolesc Psychiatry 1990;29:854.
7. Mundy P, Sheinkopf S. Social behavior and the neurology of autism. Int Pediatr 1993;8:205.
8. Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000;55:468.
9. Stone WL, Caro-Martinez LM. Naturalistic observations of spontaneous communication in autistic children. J Autism Dev Disord 1990;20:437.
10. Mundy P, Sigman M, Kasari C. A longitudinal study of joint attention and language development in autistic children. J Autism Dev Disord 1990;20:115.
11. Hobson RP. Concerning knowledge of mental states. Br J Med Psychol 1990;63:199.
12. Baron-Cohen S. The development of a theory of mind in autism: deviance and delay? Psychiatr Clin North Am 1991;14:33.
13. Baron-Cohen S. Out of sight or out of mind? Another look at deception in autism. J Child Psychol Psychiatry 1992;33:1141.
14. Calder AJ, Lawrence AD, Keane J, et al. Reading the mind from eye gaze. Neuropsychologia 2002;40:1129.
15. Lord C, Volkmar F. Genetics of childhood disorders: XLII. Autism, part 1: diagnosis and assessment in autistic spectrum disorders. J Am Acad Child Adolesc Psychiatry 2002;41:1134.
16. Schopler E, Reichler R, Renner B. Childhood Autism Rating Scale (CARS). Los Angeles: Western Psychological Services; 1986.
17. Stella J, Mundy P, Tuchman R. Social and nonsocial factors in the Childhood Autism Rating Scale. J Autism Dev Disord 1999;29:307.
18. Lord C, Rutter M, Goode S, et al. Autism diagnostic observation schedule: a standarized observation of communicative and social behavior. J Autism Dev Disord 1989;19:185.
19. LeCouteur A, Rutter M, Lord C, et al. Autism diagnostic interview: a standardized investigator-based instrument. J Auism Dev Disord 1989;19:363.
20. Lord C, Pickles A, McLennan J, et al. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord 1997;27:501.
21. Lord C, Risi S, Lambrecht L, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000;30:205.
22. Lord C, Leventhal BL, Cook EH Jr. Quantifying the phenotype in autism spectrum disorders. Am J Med Genet 2001;105:36.
23. Robertson JM, Tanguay PE, L'Ecuyer S, et al. Domains of social communication handicap in autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 1999;38:738.
24. Tuchman R, Jayakar P, Yaylali I, et al. Seizures and EEG findings in children with autism spectrum disorders. CNS Spectrums 1997;3:61.
25. Gillberg C, Coleman M. The biology of the autistic syndromes. 3rd edition. London: Mac Keith Press; 2000.
26. Szatmari P, Tuff L, Finlayson MA, et al. Asperger's syndrome and autism: neurocognitive aspects [see comments]. J Am Acad Child Adolesc Psychiatry 1990;29:130.
27. Liss M, Harel B, Fein D, et al. Predictors and correlates of adaptive functioning in children with developmental disorders. J Autism Dev Disord 2001;31:219.
28. Szatmari P, Merette C, Bryson SE, et al. Quantifying dimensions in autism: a factor-analytic study. J Am Acad Child Adolesc Psychiatry 2002;41:467.
29. Sigman M, Ungere JA, Mundy P, et al. Cognition in autistic children. In: Cohen DJ, Donellan A, editors. Handbook of autism and pervasive developmental disorders. New York: John Wiley; 1987. p. 103.
30. Frith U, Baron-Cohen S. Perception in autistic children. In: Cohen DJ, Donellan A, editors. Handbook of autism and pervasive developmental disorders. New York: John Wiley; 1987. p. 85.
31. Frith U, Morton J, Leslie AM. The cognitive basis of a biological disorder: autism. Trends Neurosci 1991;14:433.
32. Serra M, Loth FL, van Geert PL, et al. Theory of mind in children with 'lesser variants' of autism: a longitudinal study. J Child Psychol Psychiatry 2002;43:885.
33. Baron-Cohen S. Do people with autism understand what causes emotion? Child Dev 1991;62:385.
34. Kurita H. Infantile autism with speech loss before the age of thirty months. J Am Acad Child Psychiatry 1985;24:191.
35. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children. I: clinical characteristics. Pediatrics 1991;88:1211.
36. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics 1997;99:560.
37. Shinnar S, Rapin I, Arnold S, et al. Language regression in childhood. Pediatr Neurol 2001;24:183.
38. Osterling J, Dawson G. Early recognition of children with autism: a study of first birthday home videotapes. J Autism Dev Disord 1994;24:247.
39. Osterling JA, Dawson G, Munson JA. Early recognition of 1-year-old infants with autism spectrum disorder versus mental retardation. Dev Psychopathol 2002;14:239.
40. Burack JA, Volkmar FR. Development of low- and high-functioning autistic children. J Child Psychol Psychiatry 1992;33:607.
41. Dawson G. What is Childhood Disintegrative Disorder, how is it different from autism, and what is believed to be its cause? J Autism Dev Disord 2000;30:177.
42. Tuchman R, Rapin I. Epilepsy in autism. Lancet Neurology 2001;1:352.
43. Courchesne E, Townsend J, Saitoh O. The brain in infantile autism: posterior fossa structures are abnormal [see comments]. Neurology 1994;44:214.
44. Herbert MR, Harris GJ, Adrien KT, et al. Abnormal asymmetry in language association cortex in autism. Ann Neurol 2002;52:588.
45. Dawson G, Carver L, Meltzoff AN, et al. Neural correlates of face and object recognition in young children with autism spectrum disorder, developmental delay, and typical development. Child Dev 2002;73:700.
46. Schultz RT, Gauthier I, Klin A, et al. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 2000;57:331.
47. Grelotti DJ, Gauthier I, Schultz RT. Social interest and the development of cortical face specialization: what autism teaches us about face processing. Dev Psychobiol 2002;40:213.
48. Adolphs R, Baron-Cohen S, Tranel D. Impaired recognition of social emotions following amygdala damage. J Cogn Neurosci 2002;14:1264.
49. Bauman M, Kemper T. Neuroanatomic observations of the brain in autism. In: Bauman M, Kemper T, editors. The neurobiology of autism. Baltimore: John Hopkins University Press; 1994. p. 119.
50. Schmahmann J. The cerebellum in autism: clinical and anatomic perspectives. In: Bauman M, Kemper T, editors. The neurobiology of autism. Baltimore: John Hopkins University Press; 1994. p. 195.
51. Kemper TL, Bauman ML. Neuropathology of infantile autism. Mol Psychiatry 2002;7(Suppl 2):S12.
52. Bailey A, Luthert P, Dean A, et al. A clinicopathological study of autism. Brain 1998;121(Pt 5):889.
53. Casanova MF, Buxhoeveden DP, Brown C. Clinical and macroscopic correlates of minicolumnar pathology in autism. J Child Neurol 2002;17:692.
54. Casanova MF, Buxhoeveden DP, Switala AE, et al. Minicolumnar pathology in autism. Neurology 2002;58:428.
55. Courchesne E, Yeung-Courchesne BA, Press GA, et al. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med 1988;318:1349.
56. Kleiman MD, Neff S, Rosman NP. The brain in infantile autism: are posterior fossa structures abnormal? Neurology 1992;42:753.
57. Hashimoto T, Tayama M, Murakawa K, et al. Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord 1995;25:1.
58. Holttum JR, Minshew NJ, Sanders RS, et al. Magnetic resonance imaging of the posterior fossa in autism. Biol Psychiatry 1992;32:1091.
59. Courchesne E, Saitoh O, Yeung-Courchesne R, et al. Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. AJR Am J Roentgenol 1994;162:123.
60. Courchesne E. New evidence of cerebellar and brainstem hypoplasia in autistic infants, children and adolescents: the MR imaging study by Hashimoto and colleagues. J Autism Dev Disord 1995;25:19.
61. Harris NS, Courchesne E, Townsend J, et al. Neuroanatomic contributions to slowed orienting of attention in children with autism. Brain Res Cogn Brain Res 1999;8:61.
62. Mostofsky SH, Goldberg MC, Landa RJ, et al. Evidence for a deficit in procedural learning in children and adolescents with autism: implications for cerebellar contribution. J Int Neuropsychol Soc 2000;6:752.
63. Piven J, Arndt S, Bailey J, et al. An MRI study of brain size in autism. Am J Psychiatry 1995;152:1145.
64. Aylward EH, Minshew NJ, Goldstein G, et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 1999;53:2145.
65. Abell F, Krams M, Ashburner J, et al. The neuroanatomy of autism: a voxel-based whole brain analysis of structural scans. Neuroreport 1999;10:1647.
66. Sparks BF, Friedman SD, Shaw DW, et al. Brain structural abnormalities in young children with autism spectrum disorder. Neurology 2002;59:184.
67. Courchesne E, Karns CM, Davis HR, et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001;57:245.
68. Aylward EH, Minshew NJ, Field K, et al. Effects of age on brain volume and head circumference in autism. Neurology 2002;59:175.
69. Courchesne E. Abnormal early brain development in autism. Mol Psychiatry 2002;7(Suppl 2):S21.
70. Baron-Cohen S, Ring HA, Wheelwright S, et al. Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci 1999;11:1891.
71. Siegel B Jr, Asarnow R, Tanguay P, et al. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism. J Neuropsychiatry Clin Neurosci 1992;4:406.
72. Muller RA, Behen ME, Rothermel RD, et al. Brain mapping of language and auditory perception in high-functioning autistic adults: a PET study. J Autism Dev Disord 1999;29:19.
73. Happe F, Ehlers S, Fletcher P, et al. 'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport 1996;8:197.
74. Anderson GM. Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J Am Acad Child Adolesc Psychiatry 2002;41:1513.
75. Cook E Jr, Arora RC, Anderson GM, et al. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 1993;52:2005.
76. Cook E. Autism: review of neurochemical investigation. Synapse 1990;6:292.
77. Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;42:666.
78. Chugani DC, Muzik O, Behen M, et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999;45:287.
79. Lewine JD, Andrews R, Chez M, et al. Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics 1999;104:405.
80. Grillon C, Courchesne E, Akshoomoff N. Brainstem and middle latency auditory evoed potentials in autism and developmental language disorder. J Autism Dev Dis 1989;19:255.
81. Maziade M, Merette C, Cayer M, et al. Prolongation of brainstem auditory-evoked responses in autistic probands and their unaffected relatives. Arch Gen Psychiatry 2000;57:1077.
82. Nagy E, Loveland KA. Prolonged brainstem auditory evoked potentials: an autism-specific or autism-nonspecific marker. Arch Gen Psychiatry 2002;59:288.
83. Coutinho MB, Rocha V, Santos MC. Auditory brainstem response in two children with autism. Int J Pediatr Otorhinolaryngol 2002;66:81.
84. Klin A. Auditory brainstem responses in autism: brainstem dysfunction or peripheral hearing loss? J Autism Dev Disord 1993;23:15.
85. Townsend J, Westerfield M, Leaver E, et al. Event-related brain response abnormalities in autism: evidence for impaired cerebello-frontal spatial attention networks. Brain Res Cogn Brain Res 2001;11:127.
86. Ritvo ER, Jorde LB, Mason-Brothers A, et al. The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 1989;146:1032.
87. Szatmari P. Heterogeneity and the genetics of autism [see comments]. J Psychiatry Neurosci 1999;24:159.
88. Geschwind DH, Sowinski J, Lord C, et al. The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. Am J Hum Genet 2001;69:463.
89. Liu J, Nyholt DR, Magnussen P, et al. A genomewide screen for autism susceptibility loci. Am J Hum Genet 2001;69:327.
90. Lamb JA, Parr JR, Bailey AJ, et al. Autism: in search of susceptibility genes. Neuromolecular Med 2002;2:11.
91. Shao Y, Raiford KL, Wolpert CM, et al. Phenotypic homogeneity provides increased support for linkage on chromosome 2 in autistic disorder. Am J Hum Genet 2002;70:1058.
92. Borg I, Squire M, Menzel C, et al. A cryptic deletion of 2q35 including part of the PAX3 gene detected by breakpoint mapping in a child with autism and a de novo 2;8 translocation. J Med Genet 2002;39:391.
93. Cook EH Jr, Courchesne RY, Cox NJ, et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 1998;62:1077.
94. Fantes JA, Mewborn SK, Lese CM, et al. Organisation of the pericentromeric region of chromosome 15: at least four partial gene copies are amplified in patients with a proximal duplication of 15q. J Med Genet 2002;39:170.
95. Sultana R, Yu CE, Yu J, et al. Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics 2002;80:129.
96. Auranen M, Vanhala R, Varilo T, et al. A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am J Hum Genet 2002;71:777.
97. Alarcon M, Cantor RM, Liu J, et al. Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet 2002;70:60.
98. Beyer KS, Blasi F, Bacchelli E, et al. Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet 2002;111:305.
99. Andres C. Molecular genetics and animal models in autistic disorder. Brain Res Bull 2002;57:109.
100. Krebs MO, Betancur C, Leroy S, et al. Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism. Mol Psychiatry 2002;7:801.
101. Li J, Tabor HK, Nguyen L, et al. Lack of association between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families. Am J Med Genet 2002;114:24.
102. Fatemi SH, Stary JM, Egan EA. Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cell Mol Neurobiol 2002;22:139.
103. Zhang H, Liu X, Zhang C, et al. Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry 2002;7:1012.
104. Talebizadeh Z, Bittel DC, Miles JH, et al. No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD). J Med Genet 2002;39:e70.
105. Klin A, Jones W, Schultz R, et al. Defining and quantifying the social phenotype in autism. Am J Psychiatry 2002;159:895.
106. Grady CL, Keightley ML. Studies of altered social cognition in neuropsychiatric disorders using functional neuroimaging. Can J Psychiatry 2002;47:327.
107. Koegel RI, Frea WD. Treatment of social behavior in autism through the modification of pivotal social skills. J Appl Behav Anal 1993;26:369.
108. McEachin JJ, Smith T, Lovaas OI. Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard 1993;97:359.
109. Ozonoff S, Cathcart K. Effectiveness of a home program intervention for young children with autism. J Autism Dev Disord 1998;28:25.
110. Koegel RL, Koegel LK, McNerney EK. Pivotal areas in intervention for autism. J Clin Child Psychol 2001;30:19.
111. Anderson GM, Gutknecht L, Cohen DJ, et al. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 2002;7:831.
112. DeLong GR, Teague LA, McSwain Kamran M. Effects of fluoxetine treatment in young children with idiopathic autism. Dev Med Child Neurol 1998;40:551.
113. DeLong GR, Ritch CR, Burch S. Fluoxetine response in children with autistic spectrum disorders: correlation with familial major affective disorder and intellectual achievement. Dev Med Child Neurol 2002;44:652.
114. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002;347:314.
115. Tuchman R. Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders. J Autism Dev Disord 2000;30:485.
116. Di Martino A, Tuchman RF. Antiepileptic drugs: affective use in autism spectrum disorders. Pediatr Neurol 2001;25:199.
117. Lipkin WI. Banbury Center of Cold Spring Harbor meeting on microbiology, immunology and toxicology of autism and other neurodevelopmental disorders February 11-14, 2001. Mol Psychiatry 2002;7(Suppl 2):S1.
118. Krause I, He XS, Gershwin ME, et al. Brief report: immune factors in autism: a critical review. J Autism Dev Disord 2002;32:337.
119. Wakefield AJ, Puleston JM, Montgomery SM, et al. Review article: the concept of enterocolonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther 2002;16:663.
120. Scifo R, Cioni M, Nicolosi A, et al. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Ann Ist Super Sanita 1996;32:351.
121. Gupta S. Immunological treatments for autism. J Autism Dev Disord 2000;30:475.
122. Sandman CA, Touchette P, Marion S, et al. Disregulation of proopiomelanocortin and contagious maladaptive behavior. Regul Pept 2002;108:179.
123. Garvey J. Diet in autism and associated disorders. J Fam Health Care 2002;12:34.
124. Matarazzo EB. Treatment of late onset autism as a consequence of probable autommune processes related to chronic bacterial infection. World J Biol Psychiatry 2002;3:162.
125. Willemsen-Swinkels SH, Buitelaar JK, van Engeland H. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Biol Psychiatry 1996;39:1023.
126. Buitelaar JK, Willemsen-Swinkels S, Van Engeland H. Naltrexone in children with autism. J Am Acad Child Adolesc Psychiatry 1998;37:800.
127. Willemsen-Swinkels SH, Buitelaar JK, van Berckelaer-Onnes IA, et al. Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design. J Autism Dev Disord 1999;29:167.
128. Zimmerman AW. Commentary: immunological treatments for autism: in search of reasons for promising approaches. J Autism Dev Disord 2000;30:481.
129. Gilman JT, Tuchman RF. Autism and associated behavioral disorders: pharmacotherapeutic intervention. Ann Pharmacother 1995;29:47.
130. Tsai LY. Psychopharmacology in autism. Psychosom Med 1999;61:651.
131. Aman MG, Langworthy KS. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord 2000;30:451.
132. Santosh PJ, Baird G. Pharmacotherapy of target symptoms in autistic spectrum disorders. Indian J Pediatr 2001;68:427.
133. Rogers SJ. Interventions that facilitate socialization in children with autism. J Autism Dev Disord 2000;30:399.
134. Koegel LK. Interventions to facilitate communication in autism. J Autism Dev Disord 2000;30:383.
135. McConnell SR. Interventions to facilitate social interaction for young children with autism: review of available research and recommendations for educational intervention and future research. J Autism Dev Disord 2002;32:351.
136. Goldstein H. Communication intervention for children with autism: a review of treatment efficacy. J Autism Dev Disord 2002;32:373.
137. Howlin P. Prognosis in autism: do specialist treatments affect long-term outcome? Eur Child Adolesc Psychiatry 1997;6:55.
138. Kasari C. Assessing change in early intervention programs for children with autism. J Autism Dev Disord 2002;32:447.
139. Wolery M, Garfinkle AN. Measures in intervention research with young children who have autism. J Autism Dev Disord 2002;32:463.
140. Eisenberg L. Experience, brain, and behavior: the importance of a head start. Pediatrics 1999;103:1031.